(b).
| Author | Year | PPV | Scale | # Items | Item score score |
Range | Cut-off | # Obs | Times | MMM | Trimester |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Berle et al. [25] | 2005 | Anxiety | HADS-A∗ | 7 | 1_4 | 0–21 | ≥8 | 1 | Anytime | ||
|
| |||||||||||
| Copper et al. [29] | 1996 | Trait | STAI∗ | 5 | 1_5 | 20 | C | 1 | 26 ± 0.8 w | L2/E3 | |
|
| |||||||||||
| Dole et al. [31] | 2004 | PSA | PSIS∗ | 6 | 0_3 | 18 | 1 | 24–29 w | L2/E3 | ||
|
| |||||||||||
| Dominguez et al. [33] | 2005 | State, PSA | STAI, RD | 10 | 1_4 | 10–40 | ns | 3 | 18–20 w, 24–26 w, 32–36 w | Mean | 2/3 |
|
| |||||||||||
| Field et al. [34] | 2010 | Anxiety | SCID | 20 | 20–90 | 48 | 1 | 20 w | 2 | ||
|
| |||||||||||
| Glynn et al. [35] | 2008 | PSA | Rini∗ | 10 | 1_4 | 10–40 | 2 | 19.3 w, 31.0 w | Both | 2/E3 | |
|
| |||||||||||
| Goldenberg et al. [19] | 1996 | Trait | STAI | ns | ns | ns | ns | 1 | 24–26 w | L2 | |
|
| |||||||||||
| Hosseini et al. [36] | 2009 | Trait | STPI | 10 | 1_4 | 10–40 | NA | 2 | 4 m, 7 m | First | 2 |
|
| |||||||||||
| Kramer et al. [38] | 2009 | PSA | D-S∗ | 4 | 1_5 | 16 | Q | 1 | 24–26 w | L2 | |
|
| |||||||||||
| Lobel et al. [41] | 2000 | State | STAI | 20 | 1_4 | 60 | 3 | 10–20 w, 21–30 w, >31 w | 3 CC | 1/E3 | |
|
| |||||||||||
| Mancuso et al. [42] | 2004 | PSA: State | RD; STAI | 4 | 1_5 | 16 | NA | 3 | 18–20 w, 28–30 w | 2 CC | 2/E3 |
|
| |||||||||||
| McDonald et al. [43] | 2014 | State | STAI | 20 | 1_5 | 40 | 1 | <25 w | L2 | ||
|
| |||||||||||
| Orr et al. [44] | 2007 | PSA | PSEI∗ | 6 | 0_1 | 0–6 | ≥4 | 1 | 1st prenatal visit | 1 | |
|
| |||||||||||
| Peacock et al. [46] | 1995 | Anxiety | GHQ | 0–21 | Q | 1 | b | 1 | |||
|
| |||||||||||
| Perkin et al. [20] | 1993 | Anxiety | GHQ | Q | 3 | b, 28 w | Max | 1/E3 | |||
|
| |||||||||||
| Rini et al. [48] | 1999 | PSA | Wadhwa∗ | 10 | 1_4 | 30 | 1 | 28–32 w | E3 | ||
|
| |||||||||||
| Roesch et al. [14] | 2004 | State | STAI | 10 | 1_4 | 30 | 3 | 18 w, 28 w | L/E3 | ||
|
| |||||||||||
| Uguz et al. [15] | 2013 | PSA | PSA | 4 | 1_5 | 16 | 1 | 36 w GA - 8 w PP | First | 3 | |
|
| |||||||||||
| Wadhwa et al. [50] | 1993 | PSA | PAIP∗ | 5 | 0_1 | 0–5 | C | 1 | 28–30 w | L2/E3 | |
|
| |||||||||||
| Bhagwanani et al. [16] | 1997 | PSA | RD | 5 | 1_5 | 20 | 5 | 8–28 w, then + 6 w | 1/E3 | ||
|
| |||||||||||
| Andersson et al. [24] | 2004 | AD | PRIME-MD | B | 1 | 16–18 w | 2 | ||||
|
| |||||||||||
| Bindt et al. [26] | 2013 | AD | GAD-7 | 7 | 0_3 | 0–21 | ≥10 | 1 | 3 trimester | 3 | |
|
| |||||||||||
| Bödecs et al. [17] | 2011 | AD | GAD-7 | 1 | M = 8.13 | 1 | |||||
|
| |||||||||||
| Catov et al. [27] | 2010 | Trait | STAI-T | 10 | 1_4 | 10–40 | >20 | 1 | M = 17.9 | L2/E3 | |
|
| |||||||||||
| Dayan et al. [30] | 2006 | State: Trait | STAI-Y | 40 | 1_4 | 20–80 | C | 1 | 20–28 w | 2 | |
|
| |||||||||||
| Dominguez et al. [32] | 2008 | State: Trait | STAI-Y | 40 | 1_4 | 60 | 3 | 18–20 w, 24–26 w, 30–32 w | Mean | 2/E3 | |
|
| |||||||||||
| Latendresse and Ruiz [39] | 2011 | PSA | RD | 1_5 | 1 | 14–20 | 2 | ||||
|
| |||||||||||
| Lobel et al. [40] | 2008 | State | STAI | 3 | 10–25 w, 21–30 w, >30 w | 3 CC | L1/2 | ||||
|
| |||||||||||
| Amiri et al. [23] | 2010 | State | STPI | 10 | 1_4 | 30 | 1 | 20–28 w | L2/E3 | ||
|
| |||||||||||
| Rauchfuss and Maier [21] | 2011 | Anxiety: PSA | RD; Lukesch∗ | 5,3 | 0–5 0–6 |
1 | 13–24 w | 2 | |||
|
| |||||||||||
| Sanchez et al. [49] | 2013 | Anxiety | DASS-21 | 4 | ≥10 | 1 | PP | PP | |||
|
| |||||||||||
| Martini et al. [22] | 2010 | AD | DSM-IV | B | 1 | PP | PP | ||||
|
| |||||||||||
| Powell et al. [47] | 2013 | State: Trait | STAI-6 | C | 1 | Mean 19.7 | L2/E3 | ||||
|
| |||||||||||
| Ibanez et al. [37] | 2012 | State | STAI | 20 | 1_4 | 20–80 | ≥37 | 1 | 24–28 w | L2/E3 | |
|
| |||||||||||
| Levi et al. [18] | 1989 | S, P, C | CAI | 7 | ? | ? | ? | 1 | 36 w | 3 | |
|
| |||||||||||
| Pagel et al. [45] | 1990 | State | STAI | 20 | 1_4 | 20–80 | 1 | 21-36 w | L2/E3 | ||